Japan mRNA Synthesis & Manufacturing Market (2024-2029)
The Japan mRNA Synthesis & Manufacturing Market was valued at $46.46 Million in 2024 and projected to reach to $57.21 Million by 2029, representing a compound annual growth rate of 4.2%. Japan's mRNA synthesis and manufacturing market is poised for steady growth through 2029, driven by increasing adoption of mRNA-based therapeutics and vaccines.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Japan mRNA Synthesis & Manufacturing Market Trends and Insights
- Japan's position in the Asia Pacific region reflects steady advancement in biopharmaceutical infrastructure and increasing investment in mRNA-based therapeutic development.
- The market in Japan is driven by growing demand for personalized medicine, government support for biotechnology innovation, and the country's established pharmaceutical manufacturing capabilities. During the forecast period from 2024 to 2029, Japan is expected to strengthen its role as a key mRNA manufacturing hub in Asia Pacific.
- Japan's commitment to developing domestic mRNA production capacity, coupled with collaborations between local pharmaceutical companies and international biotech firms, supports market expansion.
- Regulatory frameworks in Japan continue to evolve to accommodate mRNA therapeutics, creating favorable conditions for market participants and enabling Japan to capture growing opportunities in vaccine and therapeutic mRNA manufacturing..
Key Market Statistics
- CAGR (2024-2029) 4.2% CAGR
- Market Size, 2024 ~USD 46.46 Million
- Forecast, 2029 ~USD 57.21 Million
- Country Japan
Japan mRNA Synthesis & Manufacturing Market Overview
Market Valuation :
Japan's mRNA synthesis and manufacturing market reached $46.46 million in 2024, with projected growth to $57.21 million by 2029, representing a steady 4.2% CAGR.
Biopharmaceutical Infrastructure :
Japan demonstrates advanced biopharmaceutical capabilities with increasing investments in mRNA-based therapeutic development, positioning itself as a key player in Asia Pacific innovation.
Growth Drivers :
Market expansion in Japan is fueled by rising demand for mRNA therapeutics, government support for biotech innovation, and collaborations between domestic and international pharmaceutical companies.
Regional Significance :
Japan's mRNA market reflects Asia Pacific's broader shift toward personalized medicine and vaccine development, with local manufacturers expanding production capabilities.
Japan mRNA Synthesis & Manufacturing Market Dynamics
- The country's robust pharmaceutical infrastructure, combined with government initiatives supporting biotechnology innovation, creates a favorable environment for market expansion.
- Japanese companies are investing in manufacturing capacity and R&D capabilities to meet growing domestic and regional demand. The 4.2% CAGR reflects Japan's measured but consistent advancement in mRNA technology adoption.
- Strategic partnerships between Japanese pharmaceutical firms and international biotech companies are accelerating market development.
- Regulatory support and healthcare system integration of mRNA therapies will further strengthen Japan's position in the global mRNA market landscape..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Merck KGaA
Pharmaceuticals
- Bioreactors
- Analytical Testing
- Bioanalytical Testing Services
- Cell Counters
- Data Management Services
- Thermo Fisher Scientific Inc.
- SANOFI
- Merck KGaA
- NOVARTIS
- Pfizer Inc.
Key Takeaways
- Japan's mRNA synthesis and manufacturing market is valued at $46.46 million in 2024 with projected growth to $57.21 million by 2029.
- Japan maintains a 4.2% CAGR, reflecting steady but measured growth compared to global expansion rates in the mRNA sector.
- Japan's established pharmaceutical infrastructure and government biotech initiatives position the country as a regional manufacturing leader.
- Regulatory evolution and international partnerships are accelerating mRNA therapeutic development and production capacity in Japan.
mRNA Synthesis & Manufacturing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MRNA SYNTHESIS & MODIFICATION SERVICES (Service) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5.8% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 2.23 (2024) |
| Revenue Forecast (Billions) | ~USD 2.96 (2029) |
| Segments Covered | Product, Type, Application, End User, Service, Consumables, Transcription Consumables, Purification Consumables, Analysis & Characterization Consumables |
Japan mRNA Synthesis & Manufacturing Market Report Segmentation
9 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Analysis & Characterization Consumables
- Analysis Kits And Reagents
- Chromatography Filters & Membrane
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Products
- Other Purification Consumables
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Purification Consumables
- Purification Kits & Reagents
- Rna Polymerases
- Transcription Consumables
- Vectors
By Application
- Cell & Gene Therapies
- Other Applications
- Vaccines
By End User
- Academic & Research Institutions
- Cros & Cdmos
- Cros And Cdmos
- Pharmaceutical & Biotechnology Companies
- Small-Scale Cros & Cdmos
By Service
- Manufacturing & Scale-Up Services
- Mrna Analysis & Characterization Services
- Mrna Purification Services
- Mrna Synthesis & Modification Services
By Consumables
- Analysis & Characterization Consumables
- Purification Consumables
- Transcription Consumables
By Transcription Consumables
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Rna Polymerases
- Vectors
By Purification Consumables
- Chromatography Filters & Membranes
- Other Purification Consumables
- Purification Kits & Reagents
- Purification Kits And Reagents
By Analysis & Characterization Consumables
- Analysis Kits & Reagents
- Analysis Kits And Reagents
- Other Analysis & Characterization Consumables
JAPAN: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 8.7 | 7.5 | 7.5 | 7.8 | 8.2 | 8.8 | 9.4 | 10.3 | 6.6 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 24.7 | 21.4 | 21.6 | 22.5 | 23.9 | 25.6 | 27.5 | 30.2 | 7 |
| SMALL-SCALE CROS & CDMOS | 3 | 2.6 | 2.5 | 2.6 | 2.8 | 2.9 | 3.1 | 3.4 | 5.7 |
| TOTAL | 36.3 | 31.4 | 31.6 | 32.9 | 34.9 | 37.3 | 40.1 | 43.9 | 6.8 |
JAPAN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 16.9 | 12.4 | 12.4 | 12.7 | 13.3 | 13.9 | 14.4 | 15.2 | 4.3 |
| CROS & CDMOS | 14.3 | 10.4 | 10.4 | 10.7 | 11.2 | 11.6 | 12.1 | 12.8 | 4.2 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 40 | 29.2 | 29.3 | 30.2 | 31.5 | 33 | 34.4 | 36.4 | 4.5 |
| TOTAL | 71.2 | 51.9 | 52 | 53.6 | 56 | 58.4 | 61 | 64.4 | 4.4 |
Target Audience
- Pharmaceutical Companies : Japanese and international pharma firms need Japan-specific market data to evaluate mRNA manufacturing investments, capacity planning, and market entry strategies in this growing segment.
- Contract Manufacturing Organizations (CMOs) : CMOs operating in or targeting Japan require detailed market insights to assess demand for mRNA synthesis services, pricing dynamics, and capacity expansion opportunities.
- Biotech Investors & Venture Capitalists : Investment firms focused on Japan's biotech sector need comprehensive market analysis to identify funding opportunities and evaluate portfolio companies' growth potential in mRNA manufacturing.
- Government & Policy Makers : Japanese regulatory bodies and government agencies require market intelligence to inform biotech policy, funding allocation, and infrastructure development initiatives.
- Equipment & Technology Suppliers : Manufacturers of mRNA synthesis equipment and enabling technologies need Japan market data to identify customer segments, forecast demand, and develop localized sales strategies.
Reasons to Buy this Report
- Japan-Specific Market Sizing : Access precise valuation data for Japan's mRNA market with verified 2024 baseline ($46.46M) and 2029 forecast ($57.21M), enabling accurate business planning and investment decisions.
- Competitive Landscape Intelligence : Understand Japan's unique competitive dynamics, local manufacturer capabilities, and market positioning relative to global players in the mRNA synthesis and manufacturing sector.
- Growth Opportunity Identification : Identify high-potential segments within Japan's 4.2% CAGR growth trajectory, including therapeutic applications, manufacturing partnerships, and regional expansion opportunities.
- Regulatory & Infrastructure Insights : Gain detailed understanding of Japan's biopharmaceutical regulatory environment, manufacturing standards, and government support mechanisms driving mRNA market development.
- Strategic Partnership Guidance : Leverage Japan-focused market intelligence to identify collaboration opportunities with domestic pharmaceutical companies, contract manufacturers, and research institutions.
Frequently asked questions
What is the current market size of mRNA synthesis and manufacturing in Japan?
Japan's mRNA synthesis and manufacturing market was valued at $46.46 million in 2024 according to verified market data.
What is the projected market size for Japan's mRNA synthesis market by 2029?
Japan's mRNA synthesis and manufacturing market is forecast to reach $57.21 million by 2029, representing growth from the 2024 baseline.
What is the CAGR for Japan's mRNA synthesis and manufacturing market?
Japan's mRNA synthesis and manufacturing market is expected to grow at a compound annual growth rate of 4.2% from 2024 to 2029.
What factors are driving growth in Japan's mRNA market?
Growth in Japan is driven by increasing demand for personalized medicine, government support for biotechnology, established pharmaceutical manufacturing capabilities, and regulatory framework improvements for mRNA therapeutics.
How does Japan's mRNA market compare to the global market?
Japan's 4.2% CAGR is lower than the global 5.8% CAGR, reflecting Japan's more mature market position and steady, measured expansion within the Asia Pacific region.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the mRNA synthesis and manufacturing market. Exhaustive secondary research was done to collect information on the mRNA synthesis and manufacturing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as market share analysis, MnM repository analysis, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the mRNA synthesis and manufacturing market.
Secondary Research
The market for the companies offering mRNA synthesis and manufacturing solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product & service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of blockchain vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and product-oriented perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global mRNA synthesis and manufacturing market scenario. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the pharmaceutical & biopharmaceutical industry) and the supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, as well as channels) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, and online, personal, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down approache was used to estimate and validate the total size of the mRNA synthesis and manufacturing market. These methods include market share analysis, MnM repository analysis were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research.
- The revenues generated from the mRNA synthesis and manufacturing market business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
mRNA synthesis and manufacturing refers to the process of producing messenger RNA (mRNA) through in vitro transcription, followed by various purification, and characterization steps to create high-quality mRNA products suitable for research, therapeutic, or vaccine applications. The mRNA synthesis and manufacturing market encompasses the development, production, and commercialization of messenger RNA (mRNA) products, including their synthesis via in vitro transcription, large-scale manufacturing, and formulation. This market serves various applications such as vaccines, therapeutic treatments, and potentially other areas like protein replacement. It involves specialized technologies and equipment, adherence to regulatory standards, and a global supply chain network.
The study provides an in-depth analysis of the mRNA synthesis and manufacturing market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key mRNA synthesis and manufacturing product and service providers.
Stakeholders
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Raw Material Suppliers
- Market Research and Consulting Firms
- Regulatory Agencies
- Venture Capitalists
- Government Organizations
- Industry Associations and Professional Societies
Report Objectives
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product, service, application, and region
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product by end user and service by end user
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the mRNA synthesis and manufacturing market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global mRNA synthesis and manufacturing market and comprehensively analyze their products and services portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as product/service launches, expansions, agreements, and collaborations in the mRNA synthesis and manufacturing market
- To benchmark players within the mRNA synthesis and manufacturing market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Get the Full mRNA Synthesis & Manufacturing Market Report
Full forecast, segment splits, and company analysis for all mRNA Synthesis & Manufacturing Market.
- Canada mRNA Synthesis & Manufacturing Market
- US mRNA Synthesis & Manufacturing Market
- Germany mRNA Synthesis & Manufacturing Market
- UK mRNA Synthesis & Manufacturing Market
- France mRNA Synthesis & Manufacturing Market
- Switzerland mRNA Synthesis & Manufacturing Market
- Italy mRNA Synthesis & Manufacturing Market
- Spain mRNA Synthesis & Manufacturing Market
- China mRNA Synthesis & Manufacturing Market
- India mRNA Synthesis & Manufacturing Market
- South Korea mRNA Synthesis & Manufacturing Market
- Brazil mRNA Synthesis & Manufacturing Market
- Rest Of Europe mRNA Synthesis & Manufacturing Market
- Rest Of Asia Pacific mRNA Synthesis & Manufacturing Market
- Rest Of Latin America mRNA Synthesis & Manufacturing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
